Mangiferin and its aglycone, norathyriol, improve glucose metabolism by activation of AMP-activated protein kinase
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
CONTEXT: Mangiferin has been reported to possess antidiabetic activities. Norathyriol, a xanthone aglycone, has the same structure as mangiferin, except for a C-glucosyl bond. To our best knowledge, no study has been conducted to determine and compare those two compounds on glucose consumption in vitro. OBJECTIVE: In this study, the effects of norathyriol and mangiferin on glucose consumption in normal and insulin resistance (IR) L6 myotubes were evaluated. Simultaneously, the potential mechanism of this effect was also investigated. MATERIALS AND METHODS: Normal or IR L6 myotubes were incubated with norathyriol (2.5 ∼ 10 μM, 0.625 ∼ 2.5 μM), mangiferin (10 ∼ 40 μM, 2.5 ∼ 10 μM) or rosiglitazone (20 μM) and/or 0.05 nM insulin for 24 h, respectively. The glucose consumption was assessed using the glucose oxidase method. Immunoblotting was performed to detect protein kinase B (PKB/Akt) and AMP-activated protein kinase (AMPK) phosphorylation in L6 myotubes cells. RESULTS: Norathyriol and mangiferin treatment alone increased the glucose consumption 61.9 and 56.3%, respectively, in L6 myotubes and made additional increasing with 0.05 nM insulin. In IR L6 myotubes, norathyriol treatment made increasing with or without insulin, mangiferin treatment also made increasing but only when co-treated with insulin. Immunoblotting results showed that norathyriol and mangiferin produced an increase of 1.9 - and 1.8-fold in the phosphorylation levels of the AMPK, but not in Akt. DISCUSSION AND CONCLUSION: Our findings suggest that norathyriol and mangiferin could improve the glucose utilization and insulin sensitivity by up-regulation of the phosphorylation of AMPK. Norathyriol may be considered as an active metabolite responsible for the antidiabetic activity of mangiferin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · cited 1×
“Insulin-mediated glucose transport linked to the activation of the phosphatidylinositol 3-kinase (PI3K) – Akt/PKB pathway (Taniguchi et al., 2006), so phosphorylation status of Akt was detected in this study.”
MethodThe AMP‐Activated Protein Kinase: Fuel Gauge of the Mammalian Cell?
Hardie, D. G., & Carling, D. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00259.x · Cited by 1,317
Klaman, L. D., Boss, O., Peroni, O. D., Kim, J. K., Martino, J. L., Zabolotny, J. M., Moghal, N., Lubkin, M., Kim, Y.-B., Sharpe, A. H., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.15.5479-5489.2000 · Cited by 1,235 · cited 2×
“Recent pharmacological studies have demonstrated that mangiferin modulates multiple targets: a-glucosidase (Li et al., 2004), protein tyrosine phosphatase 1B (Hu et al., 2007; Klaman et al., 2000) and glucose transporter protein 4 (GLUT4) expression and translocation (Girón et al., 2009).”
BackgroundDiabetes and obesity: the twin epidemics
Smyth, S., & Heron, A. (2006) · Nature Medicine · doi:10.1038/nm0106-75 · Cited by 643
Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats
Muruganandan, S., Srinivasan, K., Gupta, S., Gupta, P. K., & Lal, J. (2005) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2004.12.010 · Cited by 426 · cited 4×
“…an insulin sensitizer, showed weaker activity of insulin sensitizing at a concentration of 20 mM. Previous studies have shown mangiferin to be antidiabetic (Miura et al., 2001a,b; Muruganandan et al., 2005) but have poor bioavailability when orally administrated to rats (Wang et al., 2006).”
BackgroundInfluentialZierath, J. R., He, L., Gumà, A., Wahlström, E. O., Klip, A., & Wallberg-Henriksson, H. (1996) · Diabetologia · doi:10.1007/bf02658504 · Cited by 402
MIURA, T., ICHIKI, H., IWAMOTO, N., KATO, M., KUBO, M., SASAKI, H., OKADA, M., ISHIDA, T., SEINO, Y., & TANIGAWA, K. (2001) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.24.1009 · Cited by 137 · cited 3×
“…an insulin sensitizer, showed weaker activity of insulin sensitizing at a concentration of 20 mM. Previous studies have shown mangiferin to be antidiabetic (Miura et al., 2001a,b; Muruganandan et al., 2005) but have poor bioavailability when orally administrated to rats (Wang et al., 2006).”
BackgroundAndreu, G. P., Delgado, R., Velho, J. A., Curti, C., & Vercesi, A. E. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.03.007 · Cited by 122
Determination of mangiferin in rat plasma by liquid-liquid extraction with UPLC-MS/MS
Han, D., Chen, C., Zhang, C., Zhang, Y., & Tang, X. (2010) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2009.07.021 · Cited by 119 · cited 1×
“However, pharmacokinetic studies in rats given oral mangiferin have failed to detect mangiferin in plasma and urine, and the oral bioavailability was only 1.2%, suggesting poor absorption (Han et al., 2010; Wang et al., 2006).”
BackgroundInfluentialPetersen, K. F., & Shulman, G. I. (2006) · Obesity · doi:10.1038/oby.2006.280 · Cited by 87 · cited 1×
“Skeletal muscle IR is characterized by impaired insulinmediated translocation of GLUT4 to plasma membrane (Koistinen et al., 2003; Zierath et al., 1996) and decreased glucose uptake, the rate-limiting step for glucose disposal (Petersen & Shulman, 2006).”
Background
Cited by
Wang, X., Gao, L., Lin, H., Song, J., Wang, J., Yin, Y., Zhao, J., Xu, X., Li, Z., & Li, L. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.02.009 · Cited by 114
Self-citationSong, J., Li, J., Hou, F., Wang, X., & Liu, B. (2015) · Metabolism · doi:10.1016/j.metabol.2014.11.008 · Cited by 109
The management of diabetes mellitus by mangiferin: advances and prospects
Wang, M., Liang, Y., Chen, K., Wang, M., Long, X., Liu, H., Sun, Y., & He, B. (2022) · Nanoscale · doi:10.1039/d1nr06690k · Cited by 56
Tian, X., Gao, Y., Xu, Z., Lian, S., Ma, Y., Guo, X., Hu, P., Li, Z., & Huang, C. (2016) · BioFactors · doi:10.1002/biof.1291 · Cited by 34
Guo, X., Cheng, M., Hu, P., Shi, Z., Chen, S., Liu, H., Shi, H., Xu, Z., Tian, X., & Huang, C. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b03763 · Cited by 25
Metadata
- Authors
- Wang, F., Yan, J., Niu, Y., Li, Y., Lin, H., Liu, X., Liu, J., & Li, L.
- Venue
- Pharmaceutical Biology
- Publisher
- Informa UK Limited
- Published
- 2013-09-13
- Volume
- 52
- Issue
- 1
- Pages
- 68-73
- ISSN
- 0925-1618 (ISSN-L)
- 1388-0209
- 1744-5116
- OpenAlex
- W1985887883
- Cited by
- 41
- References
- 11
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mangiferin and its aglycone, norathyriol, improve glucose metabolism by activation of AMP-activated protein kinase. https://app.cochat.ai/papers/10.3109/13880209.2013.814691
- The paper
- Wang, F., Yan, J., Niu, Y., Li, Y., Lin, H., Liu, X., Liu, J., & Li, L. (2014). Mangiferin and its aglycone, norathyriol, improve glucose metabolism by activation of AMP-activated protein kinase. Pharmaceutical Biology. https://doi.org/10.3109/13880209.2013.814691
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.